Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Systems vaccinology identifies clinical and immunological correlates of SARS-CoV-2 vaccine response in solid-organ transplant recipients

Nicolas Gemander, View ORCID ProfileJulika Neumann, Rafael Veiga, Isabelle Etienne, Teresa Prezzemolo, Delphine Kemlin, Pieter Pannus, Stéphanie Depickère, Véronique Olislagers, Inès Vu Duc, Alexandra Waegemans, Margaux Gerbaux, Leoni Bücken, Hafid Dahma, Charlotte Martin, Nicolas Dauby, Maria E Goossens, Isabelle Desombere, Carlos P Roca, Mathijs Willemsen, Stanislas Goriely, Alain Le Moine, Arnaud Marchant, View ORCID ProfileAdrian Liston, View ORCID ProfileStephanie Humblet-Baron
doi: https://doi.org/10.1101/2024.04.05.24305357
Nicolas Gemander
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
2Department of Nephrology, Dialysis and Renal Transplantation, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julika Neumann
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
4VIB Center for Brain and Disease Research; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julika Neumann
Rafael Veiga
5The Babraham Institute, Immunology Programme; Cambridge, United Kingdom
6University of Cambridge, Department of Pathology; Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Etienne
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
7Chest Department, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Prezzemolo
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delphine Kemlin
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
2Department of Nephrology, Dialysis and Renal Transplantation, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter Pannus
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphanie Depickère
8Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Olislagers
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inès Vu Duc
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Waegemans
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaux Gerbaux
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leoni Bücken
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hafid Dahma
9LHUB-ULB (Laboratoire Hospitalier Universitaire de Bruxelles), Microbiology, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Martin
10Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Dauby
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
10Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria E Goossens
8Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Desombere
8Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos P Roca
5The Babraham Institute, Immunology Programme; Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathijs Willemsen
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
4VIB Center for Brain and Disease Research; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanislas Goriely
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Le Moine
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
2Department of Nephrology, Dialysis and Renal Transplantation, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnaud Marchant
1European Plotkin Institute for Vaccinology, Université Libre de Bruxelles (ULB), Brussels and ULB Centre for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Liston
5The Babraham Institute, Immunology Programme; Cambridge, United Kingdom
6University of Cambridge, Department of Pathology; Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian Liston
  • For correspondence: stephanie.humbletbaron{at}kuleuven.be adrian.liston{at}babraham.ac.uk arnaud.marchant{at}ulb.be
Stephanie Humblet-Baron
3KU Leuven, Department of Microbiology and Immunology; Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephanie Humblet-Baron
  • For correspondence: stephanie.humbletbaron{at}kuleuven.be adrian.liston{at}babraham.ac.uk arnaud.marchant{at}ulb.be
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Solid organ transplant (SOT) recipients are at enhanced risk of adverse outcomes following infectious challenges due to immunosuppressive treatment and additional comorbidities. Unfortunately, SOT recipients are also poor responders to the key medical intervention to preventing infection: vaccines. Here we performed a systems vaccinology study on a cohort of 59 kidney transplant recipients and 31 lung transplant recipients who received the mRNA Pfizer-BioNTech COVID-19 vaccine. Analyzing the immunological status of the patients prior to vaccination, we were able to identify multiple immunological associates of relatively improved vaccine responses following two or three doses of mRNA-based SARS-CoV-2 vaccine. These immunological associates predicted, with 95.0% and 93.3% accuracy, vaccine response after the second and third dose, respectively. Comparison of the immunological associates with vaccine response in SOT recipients revealed two distinct immune configurations: a non-classical configuration, distinct from the immune state of healthy subjects, associated with responses to two doses of mRNA vaccine and that could be mediated partly by the presence of double negative B cell subsets which are more prominently represented in responsive SOT recipients, and a “normalized” configuration, closer to the immune state of healthy subjects, associated with potent antibody responses to three doses of mRNA vaccine. These results suggest that immunosuppression in SOT recipients can result in distinct immune states associated with different trade-offs in vaccine responsiveness. Immune phenotyping of SOT recipients for immune constellation may be an effective approach for identifying patients most at risk of poor vaccine responses and susceptibility to vaccine-preventable diseases.

One-sentence summary SOT recipients showed distinct immune states at baseline associated with different profiles of vaccine-associated immune response.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was co-funded by the Belgian Federal Government through Sciensano and by the Fonds de la Recherche Scientifique (F.R.S.-FNRS) Belgium. This work has received funding from the KU Leuven C1 program and the European Union Horizon 2020 research and innovation programme under grant agreement No 874707 (EXIMIOUS) (to SHB and AL) and the Biotechnology and Biological Sciences Research Council (BBSRC) through Institute Strategic Program Grant funding BBS/E/B/000C0427 and BBS/E/B/000C0428 and the KU Leuven BOFZAP start-up grant (to SHB). This study was supported by the European Regional Development Fund (ERDF) of the Walloon Region (Wallonia-Biomed portfolio, 411132-957270).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of Hopital Erasme, Brussels, Belgium (references P2021/182 and A2021/156 for lung transplant recipients; P2020/284 and A2021/131 for kidney transplant recipients) and the Belgian Federal Agency for Medicines and Health Products (FAMHP, EudraCT 2021-004992-16 for lung transplant recipients; EudraCT 2021-000-412-28 for kidney transplant recipients) approved the monocentric prospective phase IV investigator-initiated study of the immunogenicity of the BNT161b2 vaccine (Pfizer-BioNTech). The ethics committee of CHU Saint-Pierre approved a 6-month study on the carriage and seroprevalence of SARS-CoV-2 in health-care workers (CE/20-04-17).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced are available online at http://flowrepository.org/id/FR-FCM-Z662

http://flowrepository.org/id/FR-FCM-Z662

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 06, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Systems vaccinology identifies clinical and immunological correlates of SARS-CoV-2 vaccine response in solid-organ transplant recipients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Systems vaccinology identifies clinical and immunological correlates of SARS-CoV-2 vaccine response in solid-organ transplant recipients
Nicolas Gemander, Julika Neumann, Rafael Veiga, Isabelle Etienne, Teresa Prezzemolo, Delphine Kemlin, Pieter Pannus, Stéphanie Depickère, Véronique Olislagers, Inès Vu Duc, Alexandra Waegemans, Margaux Gerbaux, Leoni Bücken, Hafid Dahma, Charlotte Martin, Nicolas Dauby, Maria E Goossens, Isabelle Desombere, Carlos P Roca, Mathijs Willemsen, Stanislas Goriely, Alain Le Moine, Arnaud Marchant, Adrian Liston, Stephanie Humblet-Baron
medRxiv 2024.04.05.24305357; doi: https://doi.org/10.1101/2024.04.05.24305357
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Systems vaccinology identifies clinical and immunological correlates of SARS-CoV-2 vaccine response in solid-organ transplant recipients
Nicolas Gemander, Julika Neumann, Rafael Veiga, Isabelle Etienne, Teresa Prezzemolo, Delphine Kemlin, Pieter Pannus, Stéphanie Depickère, Véronique Olislagers, Inès Vu Duc, Alexandra Waegemans, Margaux Gerbaux, Leoni Bücken, Hafid Dahma, Charlotte Martin, Nicolas Dauby, Maria E Goossens, Isabelle Desombere, Carlos P Roca, Mathijs Willemsen, Stanislas Goriely, Alain Le Moine, Arnaud Marchant, Adrian Liston, Stephanie Humblet-Baron
medRxiv 2024.04.05.24305357; doi: https://doi.org/10.1101/2024.04.05.24305357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)